Cargando…
Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318324/ https://www.ncbi.nlm.nih.gov/pubmed/27905016 http://dx.doi.org/10.1007/s40268-016-0156-6 |
_version_ | 1782509161876029440 |
---|---|
author | Sim, Meng-Kwoon Lee, Kok-Onn |
author_facet | Sim, Meng-Kwoon Lee, Kok-Onn |
author_sort | Sim, Meng-Kwoon |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5318324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-53183242017-03-03 Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects” Sim, Meng-Kwoon Lee, Kok-Onn Drugs R D Reply Springer International Publishing 2016-11-30 2017-03 /pmc/articles/PMC5318324/ /pubmed/27905016 http://dx.doi.org/10.1007/s40268-016-0156-6 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Reply Sim, Meng-Kwoon Lee, Kok-Onn Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects” |
title | Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects” |
title_full | Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects” |
title_fullStr | Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects” |
title_full_unstemmed | Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects” |
title_short | Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects” |
title_sort | author’s reply to srinivas: “a single dose-escalation study to evaluate the safety and pharmacokinetics of orally administered des-aspartate angiotensin i in healthy subjects” |
topic | Reply |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318324/ https://www.ncbi.nlm.nih.gov/pubmed/27905016 http://dx.doi.org/10.1007/s40268-016-0156-6 |
work_keys_str_mv | AT simmengkwoon authorsreplytosrinivasasingledoseescalationstudytoevaluatethesafetyandpharmacokineticsoforallyadministereddesaspartateangiotensiniinhealthysubjects AT leekokonn authorsreplytosrinivasasingledoseescalationstudytoevaluatethesafetyandpharmacokineticsoforallyadministereddesaspartateangiotensiniinhealthysubjects |